Learn More
Medchemexpress LLC Canertinib | 267243-28-7 | MFCD09837878 | 99.0% | 485.94 g/mol | C24H25ClFN5O3 | 200 MG

Supplier: Medchemexpress LLC HY10367200MG
Canertinib is an irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used as a research compound to probe EGFR/ErbB signaling. It inhibits cellular EGFR and ErbB2 autophosphorylation at low nanomolar concentrations and is provided as a solid for laboratory use.
- Irreversible EGFR/ErbB inhibitor with reported IC50s ~7.4 nM (EGFR) and ~9 nM (ErbB2).
- Suitable for in vitro and in vivo research on EGFR-driven signaling pathways.
- Provided as a solid, soluble in DMSO for preparation of stock solutions.
- Molecular formula C24H25ClFN5O3 and molecular weight ~485.94 g/mol.
- Intended for research use only; not for human or clinical applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.